Valuation: Evolutionary Genomics, Inc.

Market Cap 2.99M 2.62M 2.42M 2.24M 4.21M 288M 4.29M 28.85M 11.32M 141M 11.25M 11M 485M P/E 2021
-1.34x
P/E 2022 -2x
Enterprise Value 6.16M 5.38M 4.98M 4.6M 8.66M 592M 8.82M 59.36M 23.29M 290M 23.14M 22.63M 998M EV / Sales 2021
-
EV / Sales 2022 -
Free-Float
67.35%
Yield 2021 *
-
Yield 2022 -
1 year 0
Extreme 0.0002
0
3 years 0
Extreme 0.0002
0.45
5 years 0
Extreme 0.0002
1.05
10 years 0
Extreme 0.0002
5.71
Manager TitleAgeSince
Chief Tech/Sci/R&D Officer 71 1999-12-31
Chief Executive Officer 70 2014-09-30
Director TitleAgeSince
Chairman 70 2014-09-30
Director/Board Member 76 1999-12-31
Director/Board Member 66 2009-12-31
Date Insider Type Main position Quantity % Market Cap.
22-05-22Fiscal year

Founder

55,714 0.8422%
22-05-22Fiscal year

Chief Executive Officer

185,715 2.8074%
22-05-22Fiscal year

Founder

278,571 4.2111%
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--%-.--%-99.97% 1.33K
-0.33%+1.22%+2.91%+7.17% 50.35B
+0.55%-2.88%+382.07%+593.81% 39.32B
+0.13%-0.19%+29.79%-6.00% 34.69B
+0.86%-0.78%+21.58%+56.15% 34.08B
-1.31%-3.03%+2.51%+25.24% 26.63B
+0.13%-0.52% - - 16.49B
+1.13%-1.85%+67.36%+120.46% 15.31B
+0.23%+3.13%+14.73%+17.74% 13.8B
+1.13%-0.44%+12.34%-31.79% 12.87B
Average +0.25%-0.74%+59.25%+75.87% 24.35B
Weighted average by Cap. +0.17%-0.73%+81.04%+122.31%

Financials

2021 2022
Net sales - -
Net income -2.79M -2.44M -2.26M -2.09M -3.93M -268M -4M -26.92M -10.56M -131M -10.49M -10.26M -452M -1.93M -1.69M -1.56M -1.44M -2.72M -186M -2.77M -18.64M -7.31M -91.01M -7.27M -7.11M -313M
Net Debt 3.53M 3.08M 2.85M 2.63M 4.96M 339M 5.05M 34.01M 13.34M 166M 13.26M 12.97M 572M 3.17M 2.77M 2.56M 2.36M 4.45M 304M 4.53M 30.51M 11.97M 149M 11.89M 11.63M 513M
Logo Evolutionary Genomics, Inc.
Evolutionary Genomics, Inc. is a genomics research and development company. The Company is focused on the identification and validation of genes that impact commercially valuable traits in crops for the agriculture industry. It has performed research on crops including rice, corn, soybeans, wheat, cotton, cowpeas, beans, tomatoes, and cassava. Its core technology is its patented Adapted Traits Platform (ATP), which is used to perform molecular evolution analysis to identify positively selected genes that may have an impact on traits of interest. Positively selected candidate genes must be further tested to validate their impact on the desired traits. The Company has applied its ATP in research projects, including identifying genes responsible for increases in yield in corn, increases in yield in rice, drought tolerance and sugar content in tomatoes and pest/disease resistance in soybeans, cassava, beans, tomatoes and cotton.
Employees
3
  1. Stock Market
  2. Stocks
  3. FNAM Stock